Skip to main content
. 2024 Nov 14;5(6):1201–1214. doi: 10.1002/jha2.1046

TABLE 1.

Summary of patient characteristics.

Characteristic Discovery cohort Validation cohort
No. of patients (%)
Age > 70 years 14 (47) 11 (36)
Male sex 19 (63) 22 (73)
Karnofsky performance status >60 7 (23) 17 (56)
Elevated lactate dehydrogenase 14 (47) 20/29 (69)
Deep brain lesions 22 (73) 14/30 (47)
Altered mentation 19 (63) 9/30 (30)
Frontline treatment
HDMTX‐based chemotherapy 28 (93) 28 (93)
Others 2 (7) 2 (7)
Non‐GCB (Hans algorithm) 24 (80) 25 (83)